Topics
September 2017 | In The Back
Share:
By Brian C. Joondeph, MD, MPS
retinatoday.com/2017/08/
September 2017
Audina M. Berrocal, MD, and Linda A. Cernichiaro-Espinosa, MD
Allen C. Ho, MD, and Robert L. Avery, MD
Section Editor David S. Boyer, MD
PASCAL Endpoint Management: Subthreshold Laser Therapy for Macular Diseases
Sponsored by Topcon
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Clinical Case Compendium: Surgical Case Discussions From Thought Leaders
Editorially independent supported by advertising from Alcon and Topcon.
Gone With The Flare: Demystifying Uveitis
Sponsored by Santen
Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing (Part 2 of 2)
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.
Recent Supplements
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
View Insert
One to Watch: Hong-Uyen Hua, MD
Editorially independent supported by Abbvie and Regenxbio
Navigating Copays in Retina Care
View Supplement
Rising Stars in Retina: Fares Antaki, MDCM
Understanding Fast Progression in Geographic Atrophy
One to Watch: Jordan D. Deaner, MD
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE